Yes, alternatives to blood thinners exist, but which ones apply to you depends entirely on why you’re taking them. Most people searching this question have atrial fibrillation (AFib), a history of blood clots, or have been told they need anticoagulation after a stroke. For each of these situations, the options range from implantable devices and surgical procedures to lifestyle changes and, in limited cases, filters placed inside blood vessels. No herbal supplement has been proven to safely replace a prescription blood thinner.
Why People Look for Alternatives
Blood thinners work, but they come with a real trade-off: bleeding. Doctors weigh your stroke risk against your bleeding risk using scoring systems. One called CHA₂DS₂-VASc estimates your yearly chance of a stroke based on factors like age, heart failure, high blood pressure, diabetes, and prior strokes. Another called HAS-BLED estimates bleeding risk using factors like kidney or liver problems, prior bleeding episodes, and age over 65.
When your bleeding risk is high relative to your stroke risk, or when you’ve already had a serious bleed on anticoagulants, alternatives become a legitimate conversation. The 2023 guidelines from the American College of Cardiology and American Heart Association note that patients with a low to intermediate stroke risk (under 2% per year) can factor in additional variables, like how often their heart is actually in AFib, to decide whether anticoagulation is truly necessary.
Implantable Devices for AFib
The most established non-drug alternative for people with AFib is a small device implanted in the heart to seal off a pouch called the left atrial appendage. This is where the vast majority of stroke-causing clots form in AFib. The most widely used version is the Watchman FLX, a parachute-shaped plug delivered through a catheter in your leg during a one-time procedure.
Real-world data from a national registry of patients who received the Watchman FLX between 2020 and 2022 showed a 1.2% rate of stroke at one year and a 6.4% rate of major bleeding. The stroke rate matched what’s typically seen with blood thinners, while bleeding events were significantly lower over time compared to staying on anticoagulants long-term. At 45 days after the procedure, serious complications were uncommon: pericardial effusion requiring treatment occurred in 0.5% of patients, and device-related clot formation in 0.44%.
The catch is that you still need to take a blood thinner for a short period after the implant, usually 45 days, while tissue grows over the device. After that, most patients transition to aspirin alone or stop blood-thinning medications entirely. This device is specifically designed for people who have a good reason not to stay on long-term anticoagulation.
Surgical Options During Open-Heart Surgery
If you’re already having heart surgery for another reason, such as valve repair or bypass, your surgeon can remove or close the left atrial appendage at the same time. But the method matters enormously. A retrospective review of 137 patients found that suture closure succeeded only 23% of the time, and stapler closure had a 0% success rate by strict imaging criteria. Surgical excision, where the appendage is physically cut away, performed far better at 73% success and was associated with a stroke rate of just 0.2%, compared to 1.1% for other techniques.
A newer clip device called the AtriClip has improved outcomes considerably. In a trial of 70 patients, it achieved complete closure in over 98% of cases at three months, with no device-related complications or deaths. This is not a standalone procedure you’d have for AFib alone, but if cardiac surgery is already on the table, it’s a highly effective add-on.
IVC Filters for Blood Clots in the Legs or Lungs
For people dealing with deep vein thrombosis (DVT) or pulmonary embolism (PE) rather than AFib, the alternative landscape looks different. When you absolutely cannot take a blood thinner, perhaps because of recent major bleeding, active bleeding, or an upcoming surgery that can’t wait, doctors can place a small metal filter inside the inferior vena cava, the large vein carrying blood from your legs back to your heart. This filter catches clots before they reach your lungs.
These filters reduce the short-term risk of symptomatic pulmonary embolism, and large registry studies suggest a survival benefit in patients with massive PE. However, they don’t treat the clot itself or prevent new ones from forming. Most modern filters are retrievable, meaning they’re designed to be removed once you can safely restart anticoagulation. The American Society of Hematology considers them appropriate when there’s a true contraindication to blood thinners, not as a first-line preference.
Aspirin Is Not a Substitute
Aspirin thins the blood in a different way than prescription anticoagulants. It blocks platelets from clumping but does little to interrupt the clotting cascade that drives most AFib-related strokes. A meta-analysis comparing prescription anticoagulants to aspirin for stroke prevention found no meaningful difference in patients under 65. But in patients 75 and older, anticoagulants reduced recurrent stroke risk by 24% compared to aspirin. For most people with AFib and elevated stroke risk, aspirin alone is no longer recommended in current guidelines.
Nattokinase and Other Supplements
Nattokinase, an enzyme extracted from a fermented soybean dish called natto, is the supplement most frequently discussed as a natural blood thinner. It does have measurable effects on clot breakdown. In healthy volunteers, even a single dose increased markers of clot dissolution within four hours. A longer study found that 26 weeks of nattokinase reduced arterial plaque size and vessel wall thickness more effectively than a standard statin.
These findings are genuinely interesting, but they come with a critical caveat: no large clinical trial has tested nattokinase head-to-head against a prescription anticoagulant in patients who actually need stroke prevention. The studies so far have been small, short, or conducted in animals and healthy volunteers. Researchers have noted that nattokinase could eventually replace multiple cardiovascular drugs, but that remains speculative. Taking it instead of a prescribed blood thinner based on current evidence would mean accepting an unknown level of protection against stroke.
Other commonly cited natural blood thinners include garlic, ginger, and turmeric. Garlic contains compounds called ajoene and allicin that interfere with platelet clumping and may lower blood pressure. Turmeric has enough blood-thinning activity that supplements are warned against during pregnancy. But for all three, the actual anticoagulant effect in humans is poorly quantified, and researchers have acknowledged that the mechanisms and effective doses are not yet properly documented. None of these can be dosed or monitored the way a prescription anticoagulant can.
Exercise and Weight Loss
Lifestyle changes won’t replace a blood thinner directly, but they can lower your overall stroke risk enough to shift the risk-benefit equation. A large Korean population study of patients with AFib found that regular moderate exercise, roughly 170 to 240 minutes per week, was consistently associated with lower rates of stroke, heart failure, and death. The 2023 ACC/AHA guidelines specifically mention modifiable factors like blood pressure control as variables that can influence whether anticoagulation is necessary for patients in the intermediate-risk zone.
If your stroke risk score is borderline, losing weight, controlling blood pressure, and exercising regularly could be the difference between needing lifelong medication and safely going without it. These changes don’t eliminate clotting risk on their own, but they reduce the underlying conditions that drive it.
How to Think About Your Options
The right alternative depends on your diagnosis. If you have AFib and can’t tolerate blood thinners, a left atrial appendage closure device is the most proven non-drug option, with real-world outcomes that match anticoagulants for stroke prevention while cutting bleeding risk. If you have blood clots and face a short-term situation where anticoagulation is dangerous, an IVC filter can bridge the gap. If your stroke risk is low to intermediate, lifestyle modifications and careful risk factor management may keep you off blood thinners altogether.
What doesn’t yet exist is a supplement or food you can swap in for a prescription anticoagulant with the same confidence. The biology is promising for compounds like nattokinase, but the clinical proof isn’t there. For anyone whose doctor has recommended a blood thinner, the conversation about alternatives should start with understanding your specific risk scores and which of these options fits your situation.